OUR MISSION

We aim to accelerate the application of discoveries in cancer care through the fusion of human wisdom, data and technology.

Registration Now Open!

On Jan. 24, 2025, Cancer Digital Intelligence will host its second symposium, focused on delivering cancer care beyond the clinic.

Join us as we explore new models of care designed to enhance accessibility, personalization, and efficiency. Panel discussions will spotlight advancements in remote care models and examine patient perspectives and key considerations. The symposium will conclude with an exciting debate you won’t want to miss!

OUR VISION

The best care delivered seamlessly to people affected by cancer.

CDI UHN PMCF logos stacked on a coloured background

Who we are

Cancer Digital Intelligence (CDI) is a research and innovation program within Princess Margaret Cancer Centre.

We aim to achieve our vision through an ambitious strategy that will cultivate an adaptive digital environment that accelerates the spread and scale of digital innovation.

Our approach is grounded in partnering with patients, health teams and researchers to reimagine the future of cancer care.

What we do

CDI’s program structure is built on a strong foundation in Data Science and Analytics that will enable progress in our three strategic domains: Discovery Integration, Care Innovation, and Business Intelligence.

These elements are interconnected and allow us to leverage the power of digital intelligence to create the academic cancer centre of the future.

Bridging the clinic and lab to enable the exchange of data, tools and ideas that accelerate discovery. We aim to:

  • Seamlessly collect high-quality research data at every patient encounter.
  • Entwine data to advance discovery.
  • Accelerate the application of new discoveries in the real world.

Using digital innovation and service design to improve and streamline the continuum of care. We aim to:

  • Streamline and tailor the patient experience.
  • Enable access to care anytime, anywhere.
  • Augment health teams’ capacity to deliver patient care.

Harmonizing data and analytics to inform strategic decision-making and optimize care delivery. We aim to:

  • Unlock real time and predictive analysis to guide organizational decision-making.
  • Evaluate and enhance service delivery models.
  • Optimize clinical workflows.

Developing robust data infrastructure and deep expertise to advance novel applications of data science and artificial intelligence methods. We aim to:

  • Build expertise and capacity for large-scale data sharing, access and science.
  • Advance our understanding of data ethics and biases.
  • Lead the emergence of human-compatible artificial intelligence.

Our Foundation and Strategic Domains

strategic domains

Our core principles and enablers


Nimble strategy that adapts to the changing landscape


Pragmatic approach that balances quick wins, high-risk ventures, and long-term sustainable impact


Leverage digital tool sets and skill sets that will shift mindsets


Commitment to advance research and innovation while transitioning solutions towards operational partners


Partner with patients, health teams, researchers, organizations and industry


Engage and collaborate with clinical, education, research and digital leaders to drive meaningful change

Work with us

At CDI, we believe that collaborating with patients, health teams, researchers and external partners is essential to advancing cancer care.

Opportunities within CDI and across UHN

purple to blue gradient with molecule icon on top

REGISTRATION CLOSED

CDI Spark Award

The CDI Spark Award will provide financial support ($20,000) to four basic science trainees and give them access to data science and machine learning expertise to help them uncover previously unseen trends in their data.

REGISTRATION CLOSED

Machine Learning Challenge

This challenge will tackle the issue of ROI segmentation for radiation therapy in head and neck cancer. The goal of the challenge is to engage ML experts and clinicians in an open competition to explore their computational limitations in the space of object detection and contouring in medical imaging.

Green graphic with white gradient squares rising up

REGISTRATION CLOSED

Grand Challenge: Cancer Digital Intelligence: Scalability

This challenge is open to applicants from all UHN campuses across all disciplines. Projects should have clear trajectory and show alignment with one or more of CDI’s foundation and strategic domains. Funding will be awarded in the form of resources and expertise to support technical deployment activities and implementation at the Princess Margaret.

Meet our leadership team

Our team brings together a wide range of unique expertise in clinical care, research, informatics, product management, implementation, evaluation and data science.
Our collaborative and multi-disciplinary approach allows us to bridge the gap between clinical care, research, technology, and innovation in a changing landscape.

Alejandro Berlin
Medical Director
Profile image of Ben
Benjamin Haibe-Kains
Scientific Director
Luke Brzozowski
Partnership Lead
Tran Truong
Director, Data & Technology
Kelly Lane
Director, Operations & Project
Profile image of Mike
Mike Lovas
Director, Design & Innovation
Tony Tadic
Imaging Platform Lead

Our partners

Have a question? Let’s chat!

If you’d like to talk to someone at Cancer Digital Intelligence, send us an email using the form below.

Tweets

Three @UHN research projects have received over $4M through the Ontario Research Fund, part of a $92M investment in Ontario research!

Learn how this funding advances:
▶️#MRI tech
▶️#AI for donor lungs
▶️Muscle & joint health

Congrats to the awardees!
🔗 https://www.uhnresearch.ca/news/investing-research-excellence

UHN is proud to be ranked #1 on the list of Canada’s Top 40 Research Hospitals from @R_Infosource for the 14th year in a row!

Thanks to our incredible research community for their continued dedication to #HealthDiscovery, #care & #education!

🔗https://www.uhnresearch.ca/news/uhn-iscanadas-1-research-hospital

UHN selected as Canadian site for CAN-PRIME study, a clinical trial evaluating @neuralink implant for patients with cervical spinal cord injury and ALS.

https://www.uhn.ca/corporate/News/PressReleases/Pages/uhn-selected-canadian-site-for-can-prime-study-clinical-trial-involving-neuralink.aspx

Load More